Discover the Latest in Biomedical Research Innovation

Hunted through Prism's Analyze menu for ANCOVA? It isn't there, and GraphPad's own FAQ confirms they've never shipped one. Prism can still do it, through two documented routes most users never find: the simple-linear-regression slopes test for the parallel-slopes assumption, and multiple regression with dummy-coded groups for the adjusted comparison. Here are both step by step, plus an honest comparison with describing the same analysis in plain language instead.

A no-fluff, step-by-step scratch assay imaging protocol for images your software can actually measure. Twenty-six numbered steps take you from pixel calibration and Köhler alignment, through Time 0 capture with locked exposure, to returning to identical fields at later time points. Includes an equipment table, an acceptance-criteria checklist to run before you analyze, and a troubleshooting table mapping every common symptom to the step that fixes it.

When medical residents were surveyed on interpreting a p-value, 88% were confident they understood it and 100% got it wrong. That gap is why p-value mistakes survive peer review: nobody thinks they're making one. This piece covers the five most common errors in biomedical papers, several measured at scale in real journals: the inverse probability fallacy, the replication fallacy, 'trending toward significance', p-hacking, and treating 0.05 as a bright line.

Sophie 4.5 is live. It keeps everything that made 4.0 work and sharpens what matters: the core chat is ~40% more intelligent at the same speed, and the Regulatory Architect is 3x faster, ~25% smarter, and now wired directly into the CFR database for more accurate device classification. The Visualizer and Analytics engines get intelligence and speed bumps, and a wave of UI/UX updates came straight from how people used 4.0. Here's everything new in CLYTE's Sophie 4.5.

The statistics were the easy part; then you lost an afternoon nudging axis labels, adding error bars and significance stars, and redrawing schematics in Illustrator. Sophie's Visualizer, CLYTE's scientific illustration engine, lives in the same chat where you analyze your data, so you just describe the figure you want and get it publication-ready in seconds: data charts, experimental-design schematics, and mechanism diagrams. We walk through turning one finished analysis into

Walk into most labs and you'll find a multi-seat GraphPad Prism license that only one or two people can actually use. Prism is powerful, but its learning curve takes months, so the license sits idle while everyone waits on the lab's 'stats person.' This piece makes the case for a different GraphPad Prism alternative: Sophie, the AI you just talk to. Describe your experiment in plain English and it picks the right test, runs it, and explains the result.

A small p-value tells you a difference is probably real, not that it's big enough to matter. Statistical significance asks whether an effect is distinguishable from noise; biological significance asks whether it's large enough to change a cell, a patient, or a conclusion. Because the p-value shrinks as your sample grows, a big enough study can stamp p < 0.05 on a difference that means nothing. Here's why, with real examples, and what to report instead: effect size and confide